The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis.
The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis.
复制标题
DOI:
10.1371/journal.pone.0004220
复制
发表时间:
2009
期刊:
影响因子:
3.7
通讯作者:
Andersen AB
中科院分区:
文献类型:
--
作者:
Aabye MG;Ravn P;PrayGod G;Jeremiah K;Mugomela A;Jepsen M;Faurholt D;Range N;Friis H;Changalucha J;Andersen AB
The performance of the tuberculosis specific Interferon Gamma Release Assays (IGRAs) has not been sufficiently documented in tuberculosis- and HIV-endemic settings. This study evaluated the sensitivity of the QuantiFERON TB-Gold In-Tube (QFT-IT) in patients with culture confirmed pulmonary tuberculosis (PTB) in a TB- and HIV-endemic population and the effect of HIV-infection and CD4 cell count on test performance. 161 patients with sputum culture confirmed PTB were subjected to HIV- and QFT-IT testing and measurement of CD4 cell count. The QFT-IT was positive in 74% (119/161; 95% CI: 67–81%). Sensitivity was higher in HIV-negative (75/93) than in HIV-positive (44/68) patients (81% vs. 65%, p = 0.02) and increased with CD4 cell count in HIV-positive patients (test for trend p = 0.03). 23 patients (14%) had an indeterminate result and this proportion decreased with increasing CD4 cell count in HIV-positive patients (test for trend p = 0.03). Low CD4 cell count (<300 cells/µl) did not account for all QFT-IT indeterminate nor all negative results. Sensitivity when excluding indeterminate results was 86% (95% CI: 81–92%) and did not differ between HIV-negative and HIV–positive patients (88 vs. 83%, p = 0.39). Sensitivity of the QFT-IT for diagnosing active PTB infection was reasonable when excluding indeterminate results and in HIV-negative patients. However, since the test missed more than 10% of patients, its potential as a rule-out test for active TB disease is limited. Furthermore, test performance is impaired by low CD4 cell count in HIV-positive patients and possibly by other factors as well in both HIV-positive and HIV-negative patients. This might limit the potential of the test in populations where HIV-infection is prevalent.
登录
查看更多内容
影响因子:
3.7
作者:
Aiken AM;Hill PC;Fox A;McAdam KP;Jackson-Sillah D;Lugos MD;Donkor SA;Adegbola RA;Brookes RH
通讯作者:
Brookes RH
影响因子:
39.2
作者:
Dosanjh DP;Hinks TS;Innes JA;Deeks JJ;Pasvol G;Hackforth S;Varia H;Millington KA;Gunatheesan R;Guyot-Revol V;Lalvani A
通讯作者:
Lalvani A
影响因子:
8.4
作者:
Balcells, Maria Elvira;Perez, Carlos M.;Garcia, Patricia
通讯作者:
Garcia, Patricia
影响因子:
--
作者:
Kanunfre, Kelly Aparecida;Munhoz Leite, Olavo Henrique;Ferreira, Antonio Walter
通讯作者:
Ferreira, Antonio Walter
影响因子:
39.2
作者:
Menzies, Dick;Pai, Madhukar;Comstock, George
通讯作者:
Comstock, George